Goodbye CPAP? New sleep apnea pill cuts breathing events by 44%
A once-nightly pill cut breathing interruptions by about 44% in a major phase 3 sleep apnea trial, while improving oxygen levels and disease severity. By strengthening the muscles that keep the airway open during sleep, AD109 could offer a new option for people unable to tolerate
A once-nightly pill cut breathing interruptions by about 44% in a major phase 3 sleep apnea trial, while improving oxygen levels and disease severity. By strengthening the muscles that keep the airway open during sleep, AD109 could offer a new option for people unable to tolerate This story matters for Health & Wellness readers tracking gym. Reported by sciencedaily.com. Read the full original at the source link below.
Originally reported by sciencedaily.com. GymNews curates and briefs the health & wellness stories that matter. Our editorial policy →